Emerging Antigenic Variants at the Antigenic Site Sb in Pandemic A(H1N1)2009 Influenza Virus in Japan Detected by a Human Monoclonal Antibody

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Yasugi, Mayo ^a,b,g   Kubota Koketsu, Ritsuko ^a,c,g   Yamashita, Akifumi ^d   Kawashita, Norihito ^d   Du, Anariwa ^a,g   Misaki, Ryo ^d,g   Kuhara, Motoki ^e,g   Boonsathorn, Naphatsawan ^f,g   Fujiyama, Kazuhito ^d,g   Okuno, Yoshinobu ^c   Nakaya, Takaaki ^d,g   Ikuta, Kazuyoshi ^a,g  

^a OSAKA UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c The Research Foundation for Microbial Diseases of Osaka University   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e Medical & Biological Laboratories Co Ltd   (Japan)

^f MINISTRY OF PUBLIC HEALTH   (Thailand)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5E4; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION; HYBRIDOMA; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS A H1N1; JAPAN; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; SEQUENCE ALIGNMENT; VIRUS DETECTION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; WINTER;

ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; FLUORESCENT ANTIBODY TECHNIQUE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE;

EID: 84885701618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077892     Document Type: Article

References (50)

1. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201. doi:10.1126/science.1176225. PubMed: 19465683.
2. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459: 1122-1125. doi:10.1038/nature08182. PubMed: 19516283.
3. Ikonen N, Haanpää M, Rönkkö E, Lyytikäinen O, Kuusi M, et al. (2010) Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland. PLOS ONE 5: e13329. doi:10.1371/journal.pone.0013329. PubMed: 20975994.
4. Barr IG, Cui L, Komadina N, Lee RT, Lin RT, et al. (2010) A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill 15.
5. Mak GC, Leung CK, Cheng KC, Wong KY, Lim W, (2011) Evolution of the haemagglutinin gene of the influenza A(H1N1)2009 virus isolated in Hong Kong, 2009-2011. Euro Surveill 16.
6. WHO (2012) Recommended composition of influenza virus vaccines for use in the 2013-2014 northern hemisphere influenza season. Retrieved onpublished at whilst December year 1111 from http://www.who.int/influenza/vaccines/virus/recommendations/2013_14_north/en/. Accessed 2013 September 17.
7. Ilyushina NA, Rudneva IA, Gambaryan AS, Tuzikov AB, Bovin NV, (2004) Receptor specificity of H5 influenza virus escape mutants. Virus Res 100: 237-241. doi:10.1016/j.virusres.2003.12.032. PubMed: 15019242.
8. El-Shesheny R, Kayali G, Kandeil A, Cai Z, Barakat AB, et al. (2012) Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011. J Gen Virol 93: 2564-2574. doi:10.1099/vir.0.043299-0. PubMed: 22956735.
9. Moreno A, Lelli D, Brocchi E, Sozzi E, Vinco LJ, et al. (2013) Monoclonal antibody-based ELISA for detection of antibodies against H5 avian influenza viruses. J Virol Methods 187: 424-430. doi:10.1016/j.jviromet.2012.11.006. PubMed: 23174163.
10. Shirahata S, Katakura Y, Teruya K, (1998) Cell hybridization, hybridomas, and human hybridomas. Methods Cell Biol 57: 111-145. doi:10.1016/S0091-679X(08)61575-7. PubMed: 9648102.
11. Lonberg N, (2005) Human antibodies from transgenic animals. Nat Biotechnol 23: 1117-1125. doi:10.1038/nbt1135. PubMed: 16151405.
12. Clackson T, Hoogenboom HR, Griffiths AD, Winter G, (1991) Making antibody fragments using phage display libraries. Nature 352: 624-628. doi:10.1038/352624a0. PubMed: 1907718.
13. McCafferty J, Griffiths AD, Winter G, Chiswell DJ, (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552-554. doi:10.1038/348552a0. PubMed: 2247164.
14. Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, et al. (1991) Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182: 475-485. doi:10.1016/0042-6822(91)90588-3. PubMed: 2024485.
15. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W, (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427. doi:10.1016/0092-8674(82)90135-0. PubMed: 6186384.
16. Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, et al. (2010) Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLOS ONE 5: e8553. doi:10.1371/journal.pone.0008553. PubMed: 20049332.
17. O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, et al. (2012) Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. mBio 3([MedlinePgn:]) PubMed: 22647789.
18. Rudneva I, Ignatieva A, Timofeeva T, Shilov A, Kushch A, et al. (2012) Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin. Virus Res 166: 61-67. doi:10.1016/j.virusres.2012.03.003. PubMed: 22459010.
19. Tsibane T, Ekiert DC, Krause JC, Martinez O, Crowe JE Jr., et al. (2012) Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses. PLOS Pathog 8: e1003067. PubMed: 23236279.
20. Kubota-Koketsu R, Mizuta H, Oshita M, Ideno S, Yunoki M, et al. (2009) Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem Biophys Res Commun 387: 180-185. doi:10.1016/j.bbrc.2009.06.151. PubMed: 19580789.
21. Yasugi M, Kubota-Koketsu R, Yamashita A, Kawashita N, Du A, et al. (2013) Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus. PLOS Pathog 9: e1003150. PubMed: 23408886.
22. Okuno Y, Isegawa Y, Sasao F, Ueda S, (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67: 2552-2558. PubMed: 7682624.
23. Di Lonardo A, Buttinelli G, Amato C, Novello F, Ridolfi B, et al. (2002) Rapid methods for identification of poliovirus isolates and determination of polio neutralizing antibody titers in human sera. J Virol Methods 101: 189-196. doi:10.1016/S0166-0934(01)00437-2. PubMed: 11849697.
24. Ueda M, Daidoji T, Du A, Yang CS, Ibrahim MS, et al. (2010) Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells. J Virol 84: 3068-3078. doi:10.1128/JVI.01923-09. PubMed: 20053741.
25. Yasugi M, Nakamura S, Daidoji T, Kawashita N, Ramadhany R, et al. (2012) Frequency of D222G and Q223R hemagglutinin mutants of pandemic (H1N1) 2009 influenza virus in Japan between 2009 and 2010. PLOS ONE 7: e30946. doi:10.1371/journal.pone.0030946. PubMed: 22363521.
26. Lerdsamran H, Pittayawonganon C, Pooruk P, Mungaomklang A, Iamsirithaworn S, et al. (2011) Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population. PLOS ONE 6: e16164. doi:10.1371/journal.pone.0016164. PubMed: 21283570.
27. Gulati U, Hwang CC, Venkatramani L, Gulati S, Stray SJ, et al. (2002) Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). J Virol 76: 12274-12280. doi:10.1128/JVI.76.23.12274-12280.2002. PubMed: 12414967.
28. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr., et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360. doi:10.1126/science.1186430. PubMed: 20339031.
29. Setthapramote C, Sasaki T, Puiprom O, Limkittikul K, Pitaksajjakul P, et al. (2013) Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection (vol 423, pg 867, 2012). Biochem Biophys Res Commun 432: 200-201. doi:10.1016/j.bbrc.2013.01.107.
30. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, et al. (2009) Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326: 734-736. doi:10.1126/science.1178258. PubMed: 19900932.
31. Miyata T, Yasunaga T, (1980) Molecular evolution of mRNA: a method for estimating evolutionary rates of synonymous and amino acid substitutions from homologous nucleotide sequences and its application. J Mol Evol 16: 23-36. doi:10.1007/BF01732067. PubMed: 6449605.
32. GIRC (2011). Retrieved onpublished at whilst December year 1111 from http://www.gen-info.osaka-u.ac.jp/~uhmin/study/index_ja.html. Accessed 2013 September 17.
33. Hughes AL, Nei M, (1988) Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335: 167-170. doi:10.1038/335167a0. PubMed: 3412472.
34. Xu Z, Zhou R, Jin M, Chen H, (2010) Selection pressure on the hemagglutinin gene of influenza A (H1N1) virus: adaptation to human and swine hosts in Asia. Acta Virol 54: 113-118. doi:10.4149/av_2010_02_113. PubMed: 20545440.
35. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601. doi:10.1128/JVI.02005-07. PubMed: 17942553.
36. Katoh K, Toh H, (2008) Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 9: 286-298. doi:10.1093/bib/bbn013. PubMed: 18372315.
37. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402. doi:10.1093/nar/25.17.3389. PubMed: 9254694.
38. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425. PubMed: 3447015.
39. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739. doi:10.1093/molbev/msr121. PubMed: 21546353.
40. Shannon CE, (1948) A Mathematical Theory of Communication. Bell Syst Tech J 27: 379-656.
41. de Vries RP, de Vries E, Moore KS, Rigter A, Rottier PJ, et al. (2011) Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin. J Biol Chem 286: 5868-5875. doi:10.1074/jbc.M110.193557. PubMed: 21173148.
42. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, et al. (2011) A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin. J Virol 85: 10905-10908. doi:10.1128/JVI.00700-11. PubMed: 21849447.
43. GISRS (2013) Influenza Laboratory Surveillance Information. Retrieved onpublished at whilst December year 1111 from http://www.who.int/influenza/gisrs_laboratory/flunet/en/. Accessed 2013 September 17.
44. NIID (2013) Infectious Agents Surveillance Report. Retrieved onpublished at whilst December year 1111 from http://www.nih.go.jp/niid/ja/iasr-inf.html. Accessed 2013 September 17.
45. Ding X, Jiang L, Ke C, Yang Z, Lei C, et al. (2010) Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates. Virus Genes 41: 329-340. doi:10.1007/s11262-010-0526-z. PubMed: 20809098.
46. Arora DJ, N'Diaye M, Dea S, (1997) Genomic study of hemagglutinins of swine influenza (H1N1) viruses associated with acute and chronic respiratory diseases in pigs. Arch Virol 142: 401-412. doi:10.1007/s007050050086. PubMed: 9125053.
47. Raymond FL, Caton AJ, Cox NJ, Kendal AP, Brownlee GG, (1986) The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology 148: 275-287. doi:10.1016/0042-6822(86)90325-9. PubMed: 3942036.
48. Lambkin R, McLain L, Jones SE, Aldridge SL, Dimmock NJ, (1994) Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. J Gen Virol 75(12):: 3493-3502. doi:10.1099/0022-1317-75-12-3493. PubMed: 7527838.
49. Wilson IA, Cox NJ, (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8: 737-771. doi:10.1146/annurev.iy.08.040190.003513. PubMed: 2188678.
50. Nakagawa N, Nukuzuma S, Haratome S, Go S, Nakagawa T, et al. (2002) Emergence of an influenza B virus with antigenic change. J Clin Microbiol 40: 3068-3070. doi:10.1128/JCM.40.8.3068-3070.2002. PubMed: 12149383.